abstract |
A liquid composition comprising a GLP-1 agonist and / or a pharmacologically tolerable salt thereof and, optionally, at least one pharmaceutically acceptable excipient, in which the composition comprises methionine, as addition therapy with metformin and / or with insulin. / long-acting insulin derivatives when appropriate. |